Clinical Trial Update: A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes. [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial comparing FDG-PET and MRI for delineating target volumes in glioblastoma and discusses how FDG-PET/CT may in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Medanta Institute of Clinical Research | Conditions: Glioblastoma | Phase 2 | Status: UNKNOWN